Borui Pharmaceutical announced that the company plans to apply to the China Interbank Market Dealers Association to register to issue medium-term notes of no more than 300 million yuan, with an issuance period of no more than 5 years. The matter has been reviewed and approved by the 6th meeting of the fourth board of directors of the company and still needs to be submitted to the shareholders' meeting for consideration. The purpose of this release is to broaden the company's financing channels and reduce financing costs. The funds raised will be used for enterprise production and operation activities that meet the requirements of national laws, regulations and policies, such as R&D investment and supplementary working capital.

Borui Pharmaceutical announced that the company plans to apply to the China Interbank Market Dealers Association to register to issue medium-term notes of no more than 300 million yuan, with an issuance period of no more than 5 years. The matter has been reviewed and approved by the 6th meeting of the fourth board of directors of the company and still needs to be submitted to the shareholders' meeting for consideration. The purpose of this release is to broaden the company's financing channels and reduce financing costs. The funds raised will be used for enterprise production and operation activities that meet the requirements of national laws, regulations and policies, such as R&D investment and supplementary working capital.